-
1
-
-
0021707134
-
Phase 11 study of recombinant leukocyte A interferon (rIFN-α A) in disseminated malignant melanoma
-
Creagan ET, Ahmann DL, Green SJ, et al. Phase 11 study of recombinant leukocyte A interferon (rIFN-α A) in disseminated malignant melanoma. Cancer 1984;54:2844-9.
-
(1984)
Cancer
, vol.54
, pp. 2844-2849
-
-
Creagan, E.T.1
Ahmann, D.L.2
Green, S.J.3
-
2
-
-
0028266553
-
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
-
Rosenberg SA, Yang JC, Topalian SL, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. J Am Med Assoc 1994;271:907-13.
-
(1994)
J Am Med Assoc
, vol.271
, pp. 907-913
-
-
Rosenberg, S.A.1
Yang, J.C.2
Topalian, S.L.3
-
3
-
-
0034918104
-
Dendritic cells: On the move from bench to bedside
-
Nestle FO, Banchereau J, Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 2001;7:761-5.
-
(2001)
Nat Med
, vol.7
, pp. 761-765
-
-
Nestle, F.O.1
Banchereau, J.2
Hart, D.3
-
5
-
-
0037174674
-
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
-
Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002;298:850-4.
-
(2002)
Science
, vol.298
, pp. 850-854
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Robbins, P.F.3
-
6
-
-
0037058993
-
Adoptive T-cell therapy using antigen-specific CD8+ T-cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells
-
Yee C, Thompson JA, Byrd D, et al. Adoptive T-cell therapy using antigen-specific CD8+ T-cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 2002;99:16168-73.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 16168-16173
-
-
Yee, C.1
Thompson, J.A.2
Byrd, D.3
-
7
-
-
0037442228
-
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients
-
Meidenbauer N, Marienhagen J, Laumer M, et al. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol 2003;170:2161-9.
-
(2003)
J Immunol
, vol.170
, pp. 2161-2169
-
-
Meidenbauer, N.1
Marienhagen, J.2
Laumer, M.3
-
8
-
-
0028154509
-
Direct evidence to support the immunosurveillance concept in a human regressive melanoma
-
Mackensen A, Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Investig 1994;93:1397-402.
-
(1994)
J Clin Investig
, vol.93
, pp. 1397-1402
-
-
Mackensen, A.1
Carcelain, G.2
Viel, S.3
-
12
-
-
0032844479
-
An expanded peripheral T-cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
-
Anichini A, Molla A, Mortarini R, et al. An expanded peripheral T-cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions. J Exp Med 1999;190:651-67.
-
(1999)
J Exp Med
, vol.190
, pp. 651-667
-
-
Anichini, A.1
Molla, A.2
Mortarini, R.3
-
13
-
-
0037128179
-
Thymic selection generates a large T-cell pool recognizing a self-peptide in humans
-
Zippelius A, Pittet MJ, Batard P, et al. Thymic selection generates a large T-cell pool recognizing a self-peptide in humans. J Exp Med 2002;195:485-94.
-
(2002)
J Exp Med
, vol.195
, pp. 485-494
-
-
Zippelius, A.1
Pittet, M.J.2
Batard, P.3
-
14
-
-
0029737843
-
Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy
-
Rabinowich H, Banks M, Reichert TE, Logan TF, Kirkwood JM, Whiteside TL. Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy. Clin Cancer Res 1996;2:1263-74.
-
(1996)
Clin Cancer Res
, vol.2
, pp. 1263-1274
-
-
Rabinowich, H.1
Banks, M.2
Reichert, T.E.3
Logan, T.F.4
Kirkwood, J.M.5
Whiteside, T.L.6
-
15
-
-
0033056073
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
-
Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999;5:677-85.
-
(1999)
Nat Med
, vol.5
, pp. 677-685
-
-
Lee, P.P.1
Yee, C.2
Savage, P.A.3
-
16
-
-
0029057043
-
Loss of HLA class I antigens by melanoma cells: Molecular mechanisms, functional significance and clinical relevance
-
Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995;16:487-94.
-
(1995)
Immunol Today
, vol.16
, pp. 487-494
-
-
Ferrone, S.1
Marincola, F.M.2
-
17
-
-
0034068120
-
Generation and purification of CD8+ Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy
-
Oelke M, Moehrle U, Chen JL, et al. Generation and purification of CD8+ Melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin Cancer Res 2000;6:1997-2005.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1997-2005
-
-
Oelke, M.1
Moehrle, U.2
Chen, J.L.3
-
18
-
-
0032864995
-
Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells
-
Mackensen A, Wittnebel S, Veelken H, Noppen C, Spagnoli GC, Lindemann A. Induction and large-scale expansion of CD8+ tumor specific cytotoxic T lymphocytes from peripheral blood lymphocytes by in vitro stimulation with CD80-transfected autologous melanoma cells. Eur Cytokine Netw 1999;10:329-36.
-
(1999)
Eur Cytokine Netw
, vol.10
, pp. 329-336
-
-
Mackensen, A.1
Wittnebel, S.2
Veelken, H.3
Noppen, C.4
Spagnoli, G.C.5
Lindemann, A.6
-
19
-
-
0021952907
-
Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
-
Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985;21:235-46.
-
(1985)
Immunogenetics
, vol.21
, pp. 235-246
-
-
Salter, R.D.1
Howell, D.N.2
Cresswell, P.3
-
20
-
-
0031985814
-
Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies
-
Kishore R, Hicklin DJ, Dellaratta DV, et al. Development and characterization of mouse anti-human LMP2, LMP7, TAP1 and TAP2 monoclonal antibodies. Tissue Antigens 1998;51:129-40.
-
(1998)
Tissue Antigens
, vol.51
, pp. 129-140
-
-
Kishore, R.1
Hicklin, D.J.2
Dellaratta, D.V.3
-
21
-
-
0141756871
-
Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining
-
Ogino T, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. Tissue Antigens 2003;62:385-93.
-
(2003)
Tissue Antigens
, vol.62
, pp. 385-393
-
-
Ogino, T.1
Wang, X.2
Kato, S.3
Miyokawa, N.4
Harabuchi, Y.5
Ferrone, S.6
-
22
-
-
0028908698
-
T-cell repertoire diversity and clonal expansions in normal and clinical samples
-
Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-81.
-
(1995)
Immunol Today
, vol.16
, pp. 176-181
-
-
Pannetier, C.1
Even, J.2
Kourilsky, P.3
-
23
-
-
0035137084
-
Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines
-
Seliger B, Schreiber K, Delp K, et al. Downregulation of the constitutive tapasin expression in human tumor cells of distinct origin and its transcriptional upregulation by cytokines. Tissue Antigens 2001;57:39-45.
-
(2001)
Tissue Antigens
, vol.57
, pp. 39-45
-
-
Seliger, B.1
Schreiber, K.2
Delp, K.3
-
24
-
-
0033554726
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
-
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401:708-12.
-
(1999)
Nature
, vol.401
, pp. 708-712
-
-
Sallusto, F.1
Lenig, D.2
Forster, R.3
Lipp, M.4
Lanzavecchia, A.5
-
25
-
-
0037561928
-
Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells
-
Brenchley JM, Karandikar NJ, Betts MR, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003;101:2711-20.
-
(2003)
Blood
, vol.101
, pp. 2711-2720
-
-
Brenchley, J.M.1
Karandikar, N.J.2
Betts, M.R.3
-
26
-
-
0036109159
-
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
-
Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002;8:379-85.
-
(2002)
Nat Med
, vol.8
, pp. 379-385
-
-
Appay, V.1
Dunbar, P.R.2
Callan, M.3
-
27
-
-
0036604205
-
Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype
-
Tomiyama H, Matsuda T, Takiguchi M. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J Immunol 2002;168:5538-50.
-
(2002)
J Immunol
, vol.168
, pp. 5538-5550
-
-
Tomiyama, H.1
Matsuda, T.2
Takiguchi, M.3
-
28
-
-
0036779576
-
Functional significance of the perforin/granzyme cell death pathway
-
Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002;2:735-47.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 735-747
-
-
Trapani, J.A.1
Smyth, M.J.2
-
29
-
-
0033618504
-
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
-
Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999;285:727-9.
-
(1999)
Science
, vol.285
, pp. 727-729
-
-
Bauer, S.1
Groh, V.2
Wu, J.3
-
31
-
-
0032482177
-
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo
-
Callan MF, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998;187:1395-402.
-
(1998)
J Exp Med
, vol.187
, pp. 1395-1402
-
-
Callan, M.F.1
Tan, L.2
Annels, N.3
-
32
-
-
0027453988
-
Decreased expression of the signal transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma
-
Nakagomi H, Petersson M, Magnusson I, et al. Decreased expression of the signal transducing ζ chains in tumor-infiltrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res 1993;53:1795-8.
-
(1993)
Cancer Res
, vol.53
, pp. 1795-1798
-
-
Nakagomi, H.1
Petersson, M.2
Magnusson, I.3
-
33
-
-
0034880059
-
Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumor immunity
-
Seo N, Hayakawa S, Takigawa M, Tokura Y. Interleukin-10 expressed at early tumor sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumor immunity. Immunology 2001;103:449-57.
-
(2001)
Immunology
, vol.103
, pp. 449-457
-
-
Seo, N.1
Hayakawa, S.2
Takigawa, M.3
Tokura, Y.4
-
34
-
-
4344671644
-
Effector function of human tumor-specific CD8 T cells in melanoma lesions: A state of functional tolerance
-
Zippelius A, Batard P, Rubio-Godoy V, et al. Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of functional tolerance. Cancer Res 2004;64:2865-73.
-
(2004)
Cancer Res
, vol.64
, pp. 2865-2873
-
-
Zippelius, A.1
Batard, P.2
Rubio-Godoy, V.3
-
35
-
-
0036597371
-
CD4+ CD25+ suppressor T cells: More questions than answers
-
Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2:389-400.
-
(2002)
Nat Rev Immunol
, vol.2
, pp. 389-400
-
-
Shevach, E.M.1
-
36
-
-
0030691757
-
Phenotypic and functional separation of memory and effector human CD8+ T cells
-
Hamann D, Baars PA, Rep MH, et al. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 1997;186:1407-18.
-
(1997)
J Exp Med
, vol.186
, pp. 1407-1418
-
-
Hamann, D.1
Baars, P.A.2
Rep, M.H.3
-
37
-
-
0037468122
-
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
-
Kuss I, Donnenberg AD, Gooding W, Whiteside TL. Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck. Br J Cancer 2003;88:223-30.
-
(2003)
Br J Cancer
, vol.88
, pp. 223-230
-
-
Kuss, I.1
Donnenberg, A.D.2
Gooding, W.3
Whiteside, T.L.4
-
38
-
-
0038181111
-
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma
-
Mortarini R, Piris A, Maurichi A, et al. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma. Cancer Res 2003;63:2535-45.
-
(2003)
Cancer Res
, vol.63
, pp. 2535-2545
-
-
Mortarini, R.1
Piris, A.2
Maurichi, A.3
-
40
-
-
0028110928
-
Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity
-
Kagi D, Vignaux F, Ledermann B, et al. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 1994;265:528-30.
-
(1994)
Science
, vol.265
, pp. 528-530
-
-
Kagi, D.1
Vignaux, F.2
Ledermann, B.3
-
41
-
-
0028179056
-
Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
-
Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994;264:961-5.
-
(1994)
Science
, vol.264
, pp. 961-965
-
-
Huang, A.Y.1
Golumbek, P.2
Ahmadzadeh, M.3
Jaffee, E.4
Pardoll, D.5
Levitsky, H.6
-
42
-
-
0030752446
-
Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions
-
de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GN. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 1997;57:3223-9.
-
(1997)
Cancer Res
, vol.57
, pp. 3223-3229
-
-
De Vries, T.J.1
Fourkour, A.2
Wobbes, T.3
Verkroost, G.4
Ruiter, D.J.5
Van Muijen, G.N.6
-
43
-
-
0032555911
-
The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope
-
Theobald M, Ruppert T, Kuckelkorn U, et al. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J Exp Med 1998;188:1017-28.
-
(1998)
J Exp Med
, vol.188
, pp. 1017-1028
-
-
Theobald, M.1
Ruppert, T.2
Kuckelkorn, U.3
-
44
-
-
0029162601
-
Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ
-
Kuckelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel PM. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur J Immunol 1995;25:2605-11.
-
(1995)
Eur J Immunol
, vol.25
, pp. 2605-2611
-
-
Kuckelkorn, U.1
Frentzel, S.2
Kraft, R.3
Kostka, S.4
Groettrup, M.5
Kloetzel, P.M.6
-
45
-
-
0033980648
-
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells
-
Morel S, Levy F, Burlet-Schiltz O, et al. Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells. Immunity 2000;12:107-17.
-
(2000)
Immunity
, vol.12
, pp. 107-117
-
-
Morel, S.1
Levy, F.2
Burlet-Schiltz, O.3
|